Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 30;15(1):59.
doi: 10.1186/s13099-023-00587-4.

Elevated plasma and bile levels of corisin, a microbiota-derived proapoptotic peptide, in patients with severe acute cholangitis

Affiliations

Elevated plasma and bile levels of corisin, a microbiota-derived proapoptotic peptide, in patients with severe acute cholangitis

Ryo Nishiwaki et al. Gut Pathog. .

Abstract

Background: Acute cholangitis is a severe, life-threatening infection of the biliary system that requires early diagnosis and treatment. The Tokyo Guidelines recommend a combination of clinical, laboratory, and imaging findings for diagnosis and severity assessment, but there are still challenges in identifying severe cases that need immediate intervention. The microbiota and its derived products have been implicated in the pathogenesis of acute cholangitis. Corisin is a microbiome-derived peptide that induces cell apoptosis, acute tissue injury, and inflammation. This study aimed to evaluate the potential of plasma and bile corisin as a biomarker of acute cholangitis.

Methods: Forty patients with acute cholangitis associated with choledocholithiasis or malignant disease were enrolled. Nine patients without acute cholangitis were used as controls. Corisin was measured by enzyme immunoassays in plasma and bile samples. Patients were classified into severe and non-severe groups. The associations of plasma and bile corisin with the clinical grade of acute cholangitis and other parameters were analyzed by univariate and multivariate regression analysis.

Results: Plasma and bile corisin levels were significantly higher in patients with acute cholangitis than in controls. Patients with severe acute cholangitis had significantly higher plasma and bile corisin levels than those with non-severe form of the disease. Bile corisin level was significantly correlated with markers of inflammation, coagulation, fibrinolysis, and renal function. Univariate analysis revealed a significant association of bile corisin but a weak association of plasma corisin with the clinical grade of acute cholangitis. In contrast, multivariate analysis showed a significant relationship between plasma corisin level and the disease clinical grade. The receiver operating characteristic curve analysis showed low sensitivity but high specificity for plasma and bile corisin to detect the severity of acute cholangitis. The plasma and bile corisin sensitivity was increased when serum C-reactive protein level was included in the receiver operating characteristic curve analysis.

Conclusions: Overall, these findings suggest that plasma and bile corisin levels may be useful biomarkers for diagnosing and monitoring acute cholangitis and that corisin may play a role in the pathophysiology of the disease by modulating inflammatory, coagulation and renal pathways.

Keywords: Acute cholangitis; Apoptosis; Choledocholithiasis; Corisin; Dysbiosis; Microbiota.

PubMed Disclaimer

Conflict of interest statement

E.C.G. and T.Y. received a Research Grant from Takeda Foundation. None of the other authors declared any competing interest regarding the data reported in this manuscript.

Figures

Fig. 1
Fig. 1
Flow chart for patients’ selection. Eighty-two patients with obstructive biliary disease underwent endoscopic retrograde cholangiopancreatography. Of these, 49 patients were included in the study
Fig. 2
Fig. 2
Phylum abundance and Shannon diversity. Microbial composition analysis (A) and microbial diversity (B) assessment were performed as described under Materials and Methods. *p < 0.05. Non-AC, non-acute cholangitis patients; AC, acute cholangitis patients
Fig. 3
Fig. 3
Increased levels of plasma and bile corisin in patients with acute cholangitis. Corisin was measured by enzyme immunoassays. There were 40 patients with acute cholangitis and 9 without acute cholangitis. Data are expressed as the mean ± SEM. Statistical analysis was performed by the Mann–Whitney U test. AC, acute cholangitis. *p < 0.05; **p < 0.01
Fig. 4
Fig. 4
Increased levels of plasma and bile corisin in patients with severe acute cholangitis. Corisin was measured by enzyme immunoassays. There were 9 patients with non-cholangitis, 30 with non-severe (mild disease 18 cases + moderate disease 12 cases) acute cholangitis, and 10 with severe disease. Data are expressed as the mean ± SEM. Statistical analysis was performed by ANOVA Fisher’s predicted least significant difference test. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001
Fig. 5
Fig. 5
Significant correlation of bile corisin with inflammatory, coagulation, fibrinolysis, and renal function markers. Corisin was measured by enzyme immunoassays. Patients with (n = 40) and without (n = 9) acute cholangitis were included to evaluate the correlation. Statistical analysis was performed by Spearman correlation
Fig. 6
Fig. 6
Receiver operating characteristic (ROC) curve analysis for the diagnosis of severe acute cholangitis. The ROC curves of serum C-reactive protein (CRP), plasma corisin, and bile corisin (A) or their combination (B) were plotted to evaluate their diagnostic performance. AUC, area under the curve

Similar articles

Cited by

References

    1. Ahmed M. Acute cholangitis: an update. World J Gastrointest Pathophysiol. 2018;9(1):1–7. doi: 10.4291/wjgp.v9.i1.1. - DOI - PMC - PubMed
    1. Gomi H, Takada T, Hwang TL, Akazawa K, Mori R, Endo I, et al. Updated comprehensive epidemiology, microbiology, and outcomes among patients with acute cholangitis. J Hepatobiliary Pancreat Sci. 2017;24(6):310–318. doi: 10.1002/jhbp.452. - DOI - PubMed
    1. Mohammad Alizadeh AH. Cholangitis diagnosis, treatment and prognosis. J Clin Transl Hepatol. 2017;5(4):404–413. doi: 10.14218/JCTH.2017.00028. - DOI - PMC - PubMed
    1. Kimura Y, Takada T, Strasberg SM, Pitt HA, Gouma DJ, Garden OJ, et al. TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013;20(1):8–23. doi: 10.1007/s00534-012-0564-0. - DOI - PubMed
    1. Kasparian K, Christou CD, Petidis K, Doumas M, Giouleme O. Short vs long-course antibiotic therapy in adults with acute cholangitis: a systematic review, meta-analysis, and evidence quality assessment. World J Gastroenterol. 2023;29(19):3027–3039. doi: 10.3748/wjg.v29.i19.3027. - DOI - PMC - PubMed